113 related articles for article (PubMed ID: 12490310)
1. Combined effects of gender, skin type and polymorphic genes on clinical phenotype: use of rate of increase in numbers of basal cell carcinomas as a model system.
Ramachandran S; Fryer AA; Lovatt TJ; Smith AG; Lear JT; Jones PW; Strange RC
Cancer Lett; 2003 Jan; 189(2):175-81. PubMed ID: 12490310
[TBL] [Abstract][Full Text] [Related]
2. Basal cell carcinomas: association of allelic variants with a high-risk subgroup of patients with the multiple presentation phenotype.
Ramachandran S; Fryer AA; Smith AG; Lear JT; Bowers B; Hartland AJ; Whiteside JR; Jones PW; Strange RC
Pharmacogenetics; 2001 Apr; 11(3):247-54. PubMed ID: 11337940
[TBL] [Abstract][Full Text] [Related]
3. Truncal site and detoxifying enzyme polymorphisms significantly reduce time to presentation of further primary cutaneous basal cell carcinoma.
Lear JT; Smith AG; Heagerty AH; Bowers B; Jones PW; Gilford J; Alldersea J; Strange RC; Fryer AA
Carcinogenesis; 1997 Aug; 18(8):1499-503. PubMed ID: 9276622
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender.
Heagerty A; Smith A; English J; Lear J; Perkins W; Bowers B; Jones P; Gilford J; Alldersea J; Fryer A; Strange RC
Br J Cancer; 1996 Jan; 73(1):44-8. PubMed ID: 8554981
[TBL] [Abstract][Full Text] [Related]
5. An enhanced risk of basal cell carcinoma is associated with particular polymorphisms in the VDR and MTHFR genes.
Lesiak A; Norval M; Wodz-Naskiewicz K; Pawliczak R; Rogowski-Tylman M; Sysa-Jedrzejowska A; Sobjanek M; Wlodarkiewicz A; Narbutt J
Exp Dermatol; 2011 Oct; 20(10):800-4. PubMed ID: 21732987
[TBL] [Abstract][Full Text] [Related]
6. Presentation with multiple cutaneous basal cell carcinomas: association of glutathione S-transferase and cytochrome P450 genotypes with clinical phenotype.
Ramachandran S; Lear JT; Ramsay H; Smith AG; Bowers B; Hutchinson PE; Jones PW; Fryer AA; Strange RC
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):61-7. PubMed ID: 9950241
[TBL] [Abstract][Full Text] [Related]
7. A population-based study of hedgehog pathway gene variants in relation to the dual risk of basal cell carcinoma plus another cancer.
Jorgensen TJ; Ruczinski I; Yao Shugart Y; Wheless L; Berthier Schaad Y; Kessing B; Hoffman-Bolton J; Helzlsouer KJ; Kao WH; Francis L; Alani RM; Strickland PT; Smith MW; Alberg AJ
Cancer Epidemiol; 2012 Oct; 36(5):e288-93. PubMed ID: 22677152
[TBL] [Abstract][Full Text] [Related]
8. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci.
Clairmont A; Sies H; Ramachandran S; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
Carcinogenesis; 1999 Jul; 20(7):1235-40. PubMed ID: 10383895
[TBL] [Abstract][Full Text] [Related]
9. Potential association of single nucleotide polymorphisms in pigmentation genes with the development of basal cell carcinoma.
Kosiniak-Kamysz A; Pośpiech E; Wojas-Pelc A; Marcińska M; Branicki W
J Dermatol; 2012 Aug; 39(8):693-8. PubMed ID: 22512251
[TBL] [Abstract][Full Text] [Related]
10. Association between genetic variation within vitamin D receptor-DNA binding sites and risk of basal cell carcinoma.
Lin Y; Chahal HS; Wu W; Cho HG; Ransohoff KJ; Dai H; Tang JY; Sarin KY; Han J
Int J Cancer; 2017 May; 140(9):2085-2091. PubMed ID: 28177523
[TBL] [Abstract][Full Text] [Related]
11. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
[TBL] [Abstract][Full Text] [Related]
12. Genetic factors determining cutaneous basal cell carcinoma phenotype.
Ramachandran S; Fryer AA; Strange RC
Med Pediatr Oncol; 2001 May; 36(5):559-63. PubMed ID: 11340612
[TBL] [Abstract][Full Text] [Related]
13. Environment, phenotype and genetics: risk factors associated with BCC of the skin.
Hoban PR; Ramachandran S; Strange RC
Expert Rev Anticancer Ther; 2002 Oct; 2(5):570-9. PubMed ID: 12382525
[TBL] [Abstract][Full Text] [Related]
14. New concepts for basal cell carcinoma. Demographic, clinical, histological risk factors, and biomarkers. A systematic review of evidence regarding risk for tumor development, susceptibility for second primary and recurrence.
Kyrgidis A; Tzellos TG; Vahtsevanos K; Triaridis S
J Surg Res; 2010 Mar; 159(1):545-56. PubMed ID: 19285687
[TBL] [Abstract][Full Text] [Related]
15. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009.
van der Leest RJT; Hollestein LM; Liu L; Nijsten T; de Vries E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):382-389. PubMed ID: 28898461
[TBL] [Abstract][Full Text] [Related]
16. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
Marcil I; Stern RS
Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cancer in first-degree relatives of basal cell carcinoma patients.
van Rossum MM; Wopereis D; Hoyer T; Soerjomataram I; Schalkwijk J; van de Kerkhof PC; Kiemeney LA; Hoogerbrugge N
Arch Dermatol Res; 2009 Apr; 301(4):295-9. PubMed ID: 18985366
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma.
Yengi L; Inskip A; Gilford J; Alldersea J; Bailey L; Smith A; Lear JT; Heagerty AH; Bowers B; Hand P; Hayes JD; Jones PW; Strange RC; Fryer AA
Cancer Res; 1996 May; 56(9):1974-7. PubMed ID: 8616834
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic factors in the development of basal cell carcinoma.
Savas S; Turgut Erdemir AV; Koku Aksu AE; Gurel MS; Ozkur E
Clin Dermatol; 2017; 35(6):616-623. PubMed ID: 29191355
[TBL] [Abstract][Full Text] [Related]
20. Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.
Flohil SC; Koljenović S; de Haas ER; Overbeek LI; de Vries E; Nijsten T
Br J Dermatol; 2011 Oct; 165(4):874-81. PubMed ID: 21711333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
